Catriona McNeil Selected Research

Catriona McNeil Research Topics

17	Melanoma (Melanoma, Malignant) 01/2023 - 01/2015
8	Neoplasms (Cancer) 01/2023 - 09/2010
3	Hypophysitis 01/2018 - 04/2015
3	Colitis 01/2018 - 04/2015
3	Disease Progression 11/2017 - 06/2015
3	Breast Neoplasms (Breast Cancer) 12/2015 - 09/2010
2	Hepatitis 01/2018 - 04/2015
2	Thyroiditis 01/2018 - 04/2015
2	Pruritus (Itching) 01/2018 - 01/2015
2	Bullous Pemphigoid (Pemphigoid) 01/2018 - 11/2016
2	Body Weight (Weight, Body) 06/2015 - 01/2015
1	Neoplasm Metastasis (Metastasis) 01/2023
1	Adenocarcinoma 09/2022
1	Complementation Group D1 Fanconi Anemia 09/2022
1	Non-alcoholic Fatty Liver Disease 10/2019
1	Inflammation (Inflammations) 10/2019
1	Insulin Resistance 10/2019
1	Sarcoma (Soft Tissue Sarcoma) 01/2019
1	Hypertension (High Blood Pressure) 01/2019
1	Dehydration (Water Stress) 01/2019
1	Alveolar Soft Part Sarcoma 01/2019
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2019
1	Vomiting 01/2019
1	Proteinuria 01/2019
1	Hyperthyroidism 01/2018
1	Uveitis 01/2018
1	Infections 01/2018
1	Arthralgia (Joint Pain) 01/2018
1	Papilledema 01/2018
1	Arthritis (Polyarthritis) 01/2018
1	Brain Neoplasms (Brain Tumor) 10/2017
1	Autoimmune Diseases (Autoimmune Disease) 10/2017
1	Sarcoidosis (Schaumann Disease) 09/2017
1	Lung Neoplasms (Lung Cancer) 11/2015
1	Hyperlipidemias (Hyperlipidemia) 04/2015
1	Thrombosis (Thrombus) 04/2015
1	Dermatitis 04/2015
1	Nausea 01/2015
1	Fatigue 01/2015
1	Neoplasm Micrometastasis 12/2010

8	pembrolizumabIBA 01/2023 - 06/2015
8	IpilimumabIBA 01/2023 - 01/2015
4	Immune Checkpoint InhibitorsIBA 01/2019 - 06/2015
4	NivolumabIBA 01/2019 - 01/2015
4	SteroidsIBA 01/2018 - 04/2015
2	Messenger RNA (mRNA)IBA 10/2019 - 12/2015
2	Dacarbazine (DIC)FDA LinkGeneric 01/2019 - 01/2015
2	Biomarkers (Surrogate Marker)IBA 01/2019 - 12/2015
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2018 - 04/2015
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2023
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2023
1	GlycogenIBA 10/2019
1	Triglycerides (Triacylglycerol)IBA 10/2019
1	Programmed Cell Death 1 ReceptorIBA 01/2019
1	cediranib (AZD2171)IBA 01/2019
1	Sulfasalazine (Azulfidine)FDA LinkGeneric 01/2018
1	dabrafenibIBA 01/2018
1	trametinibIBA 01/2018
1	RNA (Ribonucleic Acid)IBA 01/2018
1	DNA (Deoxyribonucleic Acid)IBA 01/2018
1	Thyroxine (Levothyroxine)FDA LinkGeneric 01/2018
1	tributyl phosphate (TBP)IBA 11/2017
1	Chemokine ReceptorsIBA 09/2017
1	Alanine Transaminase (SGPT)IBA 01/2017
1	MicroRNAs (MicroRNA)IBA 12/2015
1	Anaplastic Lymphoma KinaseIBA 11/2015
1	CrizotinibIBA 11/2015
1	oxidized low density lipoproteinIBA 04/2015
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 04/2015
1	Methylprednisolone FDA LinkGeneric 04/2015
1	Prednisolone (Predate)FDA LinkGeneric 04/2015
1	Immunosuppressive Agents (Immunosuppressants)IBA 04/2015
1	Infliximab (Remicade)FDA Link 04/2015
1	Estrogen ReceptorsIBA 09/2010
1	Proteins (Proteins, Gene)FDA Link 09/2010

10	Therapeutics 10/2021 - 04/2015
7	Immunotherapy 10/2021 - 04/2017
5	Drug Therapy (Chemotherapy) 09/2022 - 12/2010
2	Radiotherapy 01/2019 - 12/2015
1	Analgesia 01/2018
1	Intravenous Infusions 01/2017
1	Adjuvant Radiotherapy 12/2010
1	Lymph Node Excision (Lymph Node Dissection) 12/2010